Predict rising infection risk.
Painless. At Home.

For transplant and oncology patients, infections can escalate before fever or other visible symptoms appear.

Clira is developing a fully automated at-home system that collects and analyzes a blood microsample each day, without patients handling or even seeing it.

By tracking absolute neutrophil count (ANC), CRP, and each patient’s biological trajectory over time, Clira identifies patterns associated with rising infection risk and neutropenia.

Care teams receive earlier, actionable warnings, giving them more time to assess, intervene, and prevent deterioration.

Early signal. Early action.
Fewer hospitalizations.


contact@clirahealth.com